The main objective of this trial is to investigate the effect on the exposure of metformin in plasma when administered as an oral multiple dose together with multiple oral doses of BI 764198 (Test, T) as compared to when metformin is administered as an oral multiple dose alone (Reference, R).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Metformin: Area under the concentration-time (AUC) curve of the analyte in plasma at steady state over a uniform dosing interval Ï„ (AUCÏ„,ss)
Timeframe: Up to 5 days
Metformin: Maximum measured concentration of the analyte in plasma at steady state (Cmax,ss)
Timeframe: Up to 5 days